Asparaginase
Elspar, Spectrila (asparaginase) is an enzyme pharmaceutical. Asparaginase was first approved as Elspar on 1978-01-10. It is used to treat cholelithiasis, lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma.
| Trade Name | Spectrila |
|---|---|
| Common Name | Asparaginase |
| Indication | cholelithiasis, lymphoma, precursor cell lymphoblastic leukemia-lymphoma |
| Drug Class | Enzymes |
